David M. Knott Jr’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

David M. Knott Jr’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-27,190	Closed	-$2.8M	–	161
2023 Q2	$2.8M	Sell	27,190 -14,300	-34%	-$1.51M	1.11%	20
2023 Q1	$4.53M	Buy	41,490 +1,000	+2%	+$111K	1.78%	12
2022 Q4	$4.61M	Sell	40,490 -3,000	-7%	-$249K	1.74%	13
2022 Q3	$2.69M	Hold	43,490	–	–	1.13%	19
2022 Q2	$3.47M	Buy	43,490 +10,000	+30%	+$947K	1.46%	16
2022 Q1	$3.52M	Buy	33,490 +14,490	+76%	+$1.41M	1.12%	22
2021 Q4	$2.05M	Buy	+19,000	New	+$2.07M	0.69%	36

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

David M. Knott Jr's HZNP Position: Q3 2023 in Review

David M. Knott Jr sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 27,190 shares — an estimated $2.8M sold.

David M. Knott Jr first reported a position in HZNP in Q4 2021 and held it in 7 quarters. The position peaked at $4.61M in Q4 2022. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

David M. Knott Jr reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
David M. Knott Jr sold 27,190 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $2.8M.
David M. Knott Jr first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 7 quarters.
David M. Knott Jr's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.61M in Q4 2022.
485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on David M. Knott Jr's 13F filing for Q3 2023, filed 13 Nov 2023.